[Federal Register Volume 72, Number 96 (Friday, May 18, 2007)]
[Notices]
[Page 28074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-9634]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated December 14, 2006, and published in the Federal 
Register on December 22, 2006, (71 FR 77065), Johnson Matthey Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Remifentanil (9739), a basic class of controlled substance listed in 
schedule II.
    The company plans on producing this item for sale to its customers, 
who are final dosage manufacturers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Johnson Matthey Inc to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with State and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic class of controlled substance listed.

    Dated: May 9, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-9634 Filed 5-17-07; 8:45 am]
BILLING CODE 4410-09-P